[Debates on the concomitant use of aspirin and Angiotensin converting enzyme inhibitors: will the consensus be reached?].
During last 10 years the potential interaction between aspirin and angiotensin converting enzyme inhibitors (ACEI) has received considerable attention. Retrospective analysis of randomized trials and their meta-analyses gave conflicting results concerning existence and effects of this interaction. Taking into consideration proven benefit of both aspirin and ACEI, restricting their combined use is premature. Further studies of this issue are warranted.
Lopatin
Iu M
IuM
Volgograd State Medical University, Volgograd Region Cardiology Center.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin; D032921:Consensus; D004359:Drug Therapy, Combination; D006801:Humans; D012189:Retrospective Studies
D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin